Literature DB >> 25645326

A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIV.

Brent A Moore1, Marc I Rosen, Yan Wang, Jie Shen, Karen Ablondi, Anna Sullivan, Mario Guerrero, Lisa Siqueiros, Eric S Daar, Honghu Liu.   

Abstract

Substance using HIV patients are at risk for non-adherence, and most prior interventions in this population have had only modest effects on adherence. Contingency management (CM) is a promising intervention. The Centralized Off-site Adherence Enhancement (CARE) program involved 12 telephone-delivered substance and adherence-targeted cognitive behavior therapy sessions coupled with CM for adherence to antiretroviral therapy (ART) and counseling participation. CM involved 6 weeks of escalating reinforcement for taking prescribed doses followed by 6 weeks of tapering variable rate reinforcement, and separate reinforcement for counseling ($806 possible). Participants' adherence was measured by devices which wirelessly provided real-time notification of device-opening. HIV infected patients on ART (N = 10) with recent stimulant or alcohol use completed 10.2 of 12 possible telephone sessions, spent 42.8 min/call, and rated the counseling 6.2 on a 1-7 scale. Medication adherence improved from 81 to 93 % (p = 0.04). CARE appears to be acceptable and engaging.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25645326      PMCID: PMC4498993          DOI: 10.1007/s10461-014-0990-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  41 in total

1.  Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Authors:  Nancy F Crum; Robert H Riffenburgh; Scott Wegner; Brian K Agan; Sybil A Tasker; Katherine M Spooner; Adam W Armstrong; Susan Fraser; Mark R Wallace
Journal:  J Acquir Immune Defic Syndr       Date:  2006-02-01       Impact factor: 3.731

2.  Repeated measures analyses of dose timing of antiretroviral medication and its relationship to HIV virologic outcomes.

Authors:  Honghu Liu; Loren G Miller; Carol E Golin; Ron D Hays; Tongtong Wu; Neil S Wenger; Andrew H Kaplan
Journal:  Stat Med       Date:  2007-02-28       Impact factor: 2.373

3.  Improved adherence with contingency management.

Authors:  Marc I Rosen; Kevin Dieckhaus; Thomas J McMahon; Barbara Valdes; Nancy M Petry; Joyce Cramer; Bruce Rounsaville
Journal:  AIDS Patient Care STDS       Date:  2007-01       Impact factor: 5.078

4.  Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.

Authors:  David R Bangsberg
Journal:  Clin Infect Dis       Date:  2006-08-23       Impact factor: 9.079

5.  Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors.

Authors:  Honghu Liu; Loren G Miller; Ron D Hays; Carol E Golin; Tongtong Wu; Neil S Wenger; Andrew H Kaplan
Journal:  J Acquir Immune Defic Syndr       Date:  2006-03       Impact factor: 3.731

6.  Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Authors:  Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

7.  Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578).

Authors:  Glenn J Wagner; David E Kanouse; Daniela Golinelli; Loren G Miller; Eric S Daar; Mallory D Witt; Catherine Diamond; Jeremiah G Tilles; Carol A Kemper; Robert Larsen; Miguel Goicoechea; Richard H Haubrich
Journal:  AIDS       Date:  2006-06-12       Impact factor: 4.177

8.  An Internet-based abstinence reinforcement treatment for cigarette smoking.

Authors:  Jesse Dallery; Irene M Glenn; Bethany R Raiff
Journal:  Drug Alcohol Depend       Date:  2006-08-22       Impact factor: 4.492

9.  Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial.

Authors:  James L Sorensen; Nancy A Haug; Kevin L Delucchi; Valerie Gruber; Evan Kletter; Steven L Batki; Jacqueline P Tulsky; Paul Barnett; Sharon Hall
Journal:  Drug Alcohol Depend       Date:  2006-10-23       Impact factor: 4.492

10.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

View more
  10 in total

Review 1.  Behavioral Economic Insights to Improve Medication Adherence in Adults with Chronic Conditions: A Scoping Review.

Authors:  Jacqueline Roseleur; Gillian Harvey; Nigel Stocks; Jonathan Karnon
Journal:  Patient       Date:  2019-12       Impact factor: 3.883

2.  Text-message reminders plus incentives increase adherence to antidiabetic medication in adults with type 2 diabetes.

Authors:  Bethany R Raiff; Brantley P Jarvis; Jesse Dallery
Journal:  J Appl Behav Anal       Date:  2016-07-14

3.  A Review of the Literature on Remote Monitoring Technology in Incentive-Based Interventions for Health-Related Behavior Change.

Authors:  Allison N Kurti; Danielle R Davis; Ryan Redner; Brantley P Jarvis; Ivori Zvorsky; Diana R Keith; Hypatia A Bolivar; Thomas J White; Peter Rippberger; Catherine Markesich; Gary Atwood; Stephen T Higgins
Journal:  Transl Issues Psychol Sci       Date:  2016-06

Review 4.  Challenges in the Evaluation of Interventions to Improve Engagement Along the HIV Care Continuum in the United States: A Systematic Review.

Authors:  Kathryn A Risher; Sunaina Kapoor; Alice Moji Daramola; Gabriela Paz-Bailey; Jacek Skarbinski; Kate Doyle; Kate Shearer; David Dowdy; Eli Rosenberg; Patrick Sullivan; Maunank Shah
Journal:  AIDS Behav       Date:  2017-07

5.  A Pilot Study for Testing the Effectiveness and Cost-Efficiency of Lottery Incentive in mHealth App that Promotes Walking.

Authors:  Changseok Lee; Kyong-Mee Chung
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

6.  Beliefs related to health care incentives: Comparison of substance use disorder treatment providers, medical treatment providers, and a public sample.

Authors:  Kimberly C Kirby; Matthew J Dwyer; Connor Burrows; Dustin A Fife; Elena Bresani; Mary Tabit; Bethany R Raiff
Journal:  J Subst Abuse Treat       Date:  2021-04-08

7.  Perceptions of People Living with HIV and HIV Healthcare Providers on Real-Time Measuring and Monitoring of Antiretroviral Adherence Using Ingestible Sensors: A Qualitative Study.

Authors:  Susan Kamal; Marc I Rosen; Christina Lazar; Lisa Siqueiros; Yan Wang; Eric S Daar; Honghu Liu
Journal:  AIDS Res Treat       Date:  2020-05-27

8.  Mobile telephone-delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta-analysis.

Authors:  Carol-Ann Getty; Ana Morande; Michael Lynskey; Tim Weaver; Nicola Metrebian
Journal:  Addiction       Date:  2019-07-27       Impact factor: 6.526

9.  Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot Study.

Authors:  Eric S Daar; Marc I Rosen; Yan Wang; Lisa Siqueiros; Jie Shen; Mario Guerrero; Di Xiong; John Dao; Todd Young; Katya Corado; Courtney V Fletcher; Honghu Liu
Journal:  Clin Transl Sci       Date:  2019-10-15       Impact factor: 4.689

10.  Smartphone-based incentives for promoting adherence to antiretroviral therapy: A randomized controlled trial.

Authors:  Anthony DeFulio; Amanda Devoto; Haily Traxler; David Cosottile; Michael Fingerhood; Paul Nuzzo; Jesse Dallery
Journal:  Prev Med Rep       Date:  2021-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.